MRVI Projected Dividend Yield
Cl A/Maravai LifeSciences Holdings Inc ( NASDAQ : MRVI )Maravai LifeSciences Holdings, Inc. is a life sciences company. Co. provides products that enable the development of drug therapies, diagnostics and vaccines and to support research on human diseases. Its companies provide products and services in the fields of nucleic acid synthesis and biologics safety testing to various biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies. Co. operates through two segments. Nucleic Acid Production segment is focused on the manufacturing and sale of highly modified nucleic acid products to support the needs of customer research, therapeutic and vaccine programs. 20 YEAR PERFORMANCE RESULTS |
MRVI Dividend History Detail MRVI Dividend News MRVI Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |